3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
3
OTHER_GOV
1
NIH
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
63
Neoplasms
40
Colorectal Neoplasms
30
Uterine Cervical Neoplasms
29
Carcinoma, Hepatocellular
23
Stomach Neoplasms
19
Prostatic Neoplasms
19
Carcinoma, Non-Small-Cell Lung
19
Ovarian Neoplasms
16
Lung Neoplasms
14
Esophageal Neoplasms
13
Multiple Myeloma
12
Pancreatic Neoplasms
11
Endometrial Neoplasms
10
Urinary Bladder Neoplasms
9
Motor Activity
9
Colonic Neoplasms
9
Recurrence
8
Rectal Neoplasms
8
Lymphoma, Follicular
8
Melanoma
7
Lymphoma
7
Liver Neoplasms
7
Carcinoma, Ovarian Epithelial
7
Triple Negative Breast Neoplasms
6
Sleep Initiation and Maintenance Disorders
6
Sarcopenia
6
Neuroendocrine Tumors
6
Leukemia
6
Hematologic Neoplasms
6
Interventions
Raltegravir Potassium
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Liver Failure
×
1 year
×
Clear all
NCT01022476
2026-04-06
LIVERAL
ANRS, Emerging Infectious Diseases
Phase 1/2
Completed
14 enrolled